sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


COVID-19 Impact on Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026

Category : Pharmaceuticals and Healthcare QY Research Pages :125
Published Date : 2020-09-16

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Parkinsons Disease Therapeutics Market with our analysts monitoring the situation across the globe.
This report focuses on the global Parkinson's Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson's Disease Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie Merck Akorn Kyowa Hakko Kirin Pharma Astellas Pharma Desitin Arzneimittel Endo Pharmaceuticals F.Hoffmann-La Roche H.Lundbeck Valeant Apokyn Orion Stada Arzneimittel US WorldMeds Bausch Health Market segment by Type, the product can be split into Medications Therapeutics Medical Devices Therapeutics Market segment by Application, split into Under 40 Years Old 40-65 Years Old Above 65 Years Old Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Parkinson's Disease Therapeutics status, future forecast, growth opportunity, key market and key players. To present the Parkinson's Disease Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of Parkinson's Disease Therapeutics are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Medications Therapeutics 1.4.3 Medical Devices Therapeutics 1.5 Market by Application 1.5.1 Global Parkinson's Disease Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Under 40 Years Old 1.5.3 40-65 Years Old 1.5.4 Above 65 Years Old 1.6 Coronavirus Disease 2019 (Covid-19): Parkinson's Disease Therapeutics Industry Impact 1.6.1 How the Covid-19 is Affecting the Parkinson's Disease Therapeutics Industry 1.6.1.1 Parkinson's Disease Therapeutics Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Parkinson's Disease Therapeutics Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Parkinson's Disease Therapeutics Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Parkinson's Disease Therapeutics Market Perspective (2015-2026) 2.2 Parkinson's Disease Therapeutics Growth Trends by Regions 2.2.1 Parkinson's Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Parkinson's Disease Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Parkinson's Disease Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Parkinson's Disease Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Parkinson's Disease Therapeutics Players by Market Size 3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Parkinson's Disease Therapeutics Market Concentration Ratio 3.2.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2019 3.3 Parkinson's Disease Therapeutics Key Players Head office and Area Served 3.4 Key Players Parkinson's Disease Therapeutics Product Solution and Service 3.5 Date of Enter into Parkinson's Disease Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2021-2026) 5 Parkinson's Disease Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Parkinson's Disease Therapeutics Market Size by Application (2015-2020) 5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Parkinson's Disease Therapeutics Market Size (2015-2020) 6.2 Parkinson's Disease Therapeutics Key Players in North America (2019-2020) 6.3 North America Parkinson's Disease Therapeutics Market Size by Type (2015-2020) 6.4 North America Parkinson's Disease Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Parkinson's Disease Therapeutics Market Size (2015-2020) 7.2 Parkinson's Disease Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Parkinson's Disease Therapeutics Market Size by Type (2015-2020) 7.4 Europe Parkinson's Disease Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China Parkinson's Disease Therapeutics Market Size (2015-2020) 8.2 Parkinson's Disease Therapeutics Key Players in China (2019-2020) 8.3 China Parkinson's Disease Therapeutics Market Size by Type (2015-2020) 8.4 China Parkinson's Disease Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Parkinson's Disease Therapeutics Market Size (2015-2020) 9.2 Parkinson's Disease Therapeutics Key Players in Japan (2019-2020) 9.3 Japan Parkinson's Disease Therapeutics Market Size by Type (2015-2020) 9.4 Japan Parkinson's Disease Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Parkinson's Disease Therapeutics Market Size (2015-2020) 10.2 Parkinson's Disease Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India Parkinson's Disease Therapeutics Market Size (2015-2020) 11.2 Parkinson's Disease Therapeutics Key Players in India (2019-2020) 11.3 India Parkinson's Disease Therapeutics Market Size by Type (2015-2020) 11.4 India Parkinson's Disease Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Parkinson's Disease Therapeutics Market Size (2015-2020) 12.2 Parkinson's Disease Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America Parkinson's Disease Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America Parkinson's Disease Therapeutics Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 GSK 13.1.1 GSK Company Details 13.1.2 GSK Business Overview and Its Total Revenue 13.1.3 GSK Parkinson's Disease Therapeutics Introduction 13.1.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2015-2020)) 13.1.5 GSK Recent Development 13.2 Novartis 13.2.1 Novartis Company Details 13.2.2 Novartis Business Overview and Its Total Revenue 13.2.3 Novartis Parkinson's Disease Therapeutics Introduction 13.2.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 13.2.5 Novartis Recent Development 13.3 Boehringer Ingelheim 13.3.1 Boehringer Ingelheim Company Details 13.3.2 Boehringer Ingelheim Business Overview and Its Total Revenue 13.3.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction 13.3.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 13.3.5 Boehringer Ingelheim Recent Development 13.4 Teva Pharmaceutical 13.4.1 Teva Pharmaceutical Company Details 13.4.2 Teva Pharmaceutical Business Overview and Its Total Revenue 13.4.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction 13.4.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 13.4.5 Teva Pharmaceutical Recent Development 13.5 Abbvie 13.5.1 Abbvie Company Details 13.5.2 Abbvie Business Overview and Its Total Revenue 13.5.3 Abbvie Parkinson's Disease Therapeutics Introduction 13.5.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 13.5.5 Abbvie Recent Development 13.6 Merck 13.6.1 Merck Company Details 13.6.2 Merck Business Overview and Its Total Revenue 13.6.3 Merck Parkinson's Disease Therapeutics Introduction 13.6.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 13.6.5 Merck Recent Development 13.7 Akorn 13.7.1 Akorn Company Details 13.7.2 Akorn Business Overview and Its Total Revenue 13.7.3 Akorn Parkinson's Disease Therapeutics Introduction 13.7.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 13.7.5 Akorn Recent Development 13.8 Kyowa Hakko Kirin Pharma 13.8.1 Kyowa Hakko Kirin Pharma Company Details 13.8.2 Kyowa Hakko Kirin Pharma Business Overview and Its Total Revenue 13.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction 13.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 13.8.5 Kyowa Hakko Kirin Pharma Recent Development 13.9 Astellas Pharma 13.9.1 Astellas Pharma Company Details 13.9.2 Astellas Pharma Business Overview and Its Total Revenue 13.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction 13.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 13.9.5 Astellas Pharma Recent Development 13.10 Desitin Arzneimittel 13.10.1 Desitin Arzneimittel Company Details 13.10.2 Desitin Arzneimittel Business Overview and Its Total Revenue 13.10.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction 13.10.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 13.10.5 Desitin Arzneimittel Recent Development 13.11 Endo Pharmaceuticals 10.11.1 Endo Pharmaceuticals Company Details 10.11.2 Endo Pharmaceuticals Business Overview and Its Total Revenue 10.11.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction 10.11.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 10.11.5 Endo Pharmaceuticals Recent Development 13.12 F.Hoffmann-La Roche 10.12.1 F.Hoffmann-La Roche Company Details 10.12.2 F.Hoffmann-La Roche Business Overview and Its Total Revenue 10.12.3 F.Hoffmann-La Roche Parkinson's Disease Therapeutics Introduction 10.12.4 F.Hoffmann-La Roche Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 10.12.5 F.Hoffmann-La Roche Recent Development 13.13 H.Lundbeck 10.13.1 H.Lundbeck Company Details 10.13.2 H.Lundbeck Business Overview and Its Total Revenue 10.13.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction 10.13.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 10.13.5 H.Lundbeck Recent Development 13.14 Valeant 10.14.1 Valeant Company Details 10.14.2 Valeant Business Overview and Its Total Revenue 10.14.3 Valeant Parkinson's Disease Therapeutics Introduction 10.14.4 Valeant Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 10.14.5 Valeant Recent Development 13.15 Apokyn 10.15.1 Apokyn Company Details 10.15.2 Apokyn Business Overview and Its Total Revenue 10.15.3 Apokyn Parkinson's Disease Therapeutics Introduction 10.15.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 10.15.5 Apokyn Recent Development 13.16 Orion 10.16.1 Orion Company Details 10.16.2 Orion Business Overview and Its Total Revenue 10.16.3 Orion Parkinson's Disease Therapeutics Introduction 10.16.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 10.16.5 Orion Recent Development 13.17 Stada Arzneimittel 10.17.1 Stada Arzneimittel Company Details 10.17.2 Stada Arzneimittel Business Overview and Its Total Revenue 10.17.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction 10.17.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 10.17.5 Stada Arzneimittel Recent Development 13.18 US WorldMeds 10.18.1 US WorldMeds Company Details 10.18.2 US WorldMeds Business Overview and Its Total Revenue 10.18.3 US WorldMeds Parkinson's Disease Therapeutics Introduction 10.18.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 10.18.5 US WorldMeds Recent Development 13.19 Bausch Health 10.19.1 Bausch Health Company Details 10.19.2 Bausch Health Business Overview and Its Total Revenue 10.19.3 Bausch Health Parkinson's Disease Therapeutics Introduction 10.19.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2015-2020) 10.19.5 Bausch Health Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

Get Free Sample

List of Tables Table 1. Parkinson's Disease Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue Table 3. Ranking of Global Top Parkinson's Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Medications Therapeutics Table 6. Key Players of Medical Devices Therapeutics Table 7. COVID-19 Impact Global Market: (Four Parkinson's Disease Therapeutics Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Parkinson's Disease Therapeutics Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Parkinson's Disease Therapeutics Players to Combat Covid-19 Impact Table 12. Global Parkinson's Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Parkinson's Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Parkinson's Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Parkinson's Disease Therapeutics Market Share by Regions (2015-2020) Table 16. Global Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Parkinson's Disease Therapeutics Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Parkinson's Disease Therapeutics Market Growth Strategy Table 22. Main Points Interviewed from Key Parkinson's Disease Therapeutics Players Table 23. Global Parkinson's Disease Therapeutics Revenue by Players (2015-2020) (Million US$) Table 24. Global Parkinson's Disease Therapeutics Market Share by Players (2015-2020) Table 25. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2019) Table 26. Global Parkinson's Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Parkinson's Disease Therapeutics Product Solution and Service Table 29. Date of Enter into Parkinson's Disease Therapeutics Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 32. Global Parkinson's Disease Therapeutics Market Size Share by Type (2015-2020) Table 33. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2021-2026) Table 34. Global Parkinson's Disease Therapeutics Market Size Share by Application (2015-2020) Table 35. Global Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 36. Global Parkinson's Disease Therapeutics Market Size Share by Application (2021-2026) Table 37. North America Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$) Table 38. North America Key Players Parkinson's Disease Therapeutics Market Share (2019-2020) Table 39. North America Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 40. North America Parkinson's Disease Therapeutics Market Share by Type (2015-2020) Table 41. North America Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 42. North America Parkinson's Disease Therapeutics Market Share by Application (2015-2020) Table 43. Europe Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Parkinson's Disease Therapeutics Market Share (2019-2020) Table 45. Europe Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 46. Europe Parkinson's Disease Therapeutics Market Share by Type (2015-2020) Table 47. Europe Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 48. Europe Parkinson's Disease Therapeutics Market Share by Application (2015-2020) Table 49. China Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$) Table 50. China Key Players Parkinson's Disease Therapeutics Market Share (2019-2020) Table 51. China Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 52. China Parkinson's Disease Therapeutics Market Share by Type (2015-2020) Table 53. China Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 54. China Parkinson's Disease Therapeutics Market Share by Application (2015-2020) Table 55. Japan Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$) Table 56. Japan Key Players Parkinson's Disease Therapeutics Market Share (2019-2020) Table 57. Japan Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 58. Japan Parkinson's Disease Therapeutics Market Share by Type (2015-2020) Table 59. Japan Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 60. Japan Parkinson's Disease Therapeutics Market Share by Application (2015-2020) Table 61. Southeast Asia Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$) Table 62. Southeast Asia Key Players Parkinson's Disease Therapeutics Market Share (2019-2020) Table 63. Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 64. Southeast Asia Parkinson's Disease Therapeutics Market Share by Type (2015-2020) Table 65. Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 66. Southeast Asia Parkinson's Disease Therapeutics Market Share by Application (2015-2020) Table 67. India Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$) Table 68. India Key Players Parkinson's Disease Therapeutics Market Share (2019-2020) Table 69. India Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 70. India Parkinson's Disease Therapeutics Market Share by Type (2015-2020) Table 71. India Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 72. India Parkinson's Disease Therapeutics Market Share by Application (2015-2020) Table 73. Central & South America Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players Parkinson's Disease Therapeutics Market Share (2019-2020) Table 75. Central & South America Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America Parkinson's Disease Therapeutics Market Share by Type (2015-2020) Table 77. Central & South America Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America Parkinson's Disease Therapeutics Market Share by Application (2015-2020) Table 79. GSK Company Details Table 80. GSK Business Overview Table 81. GSK Product Table 82. GSK Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 83. GSK Recent Development Table 84. Novartis Company Details Table 85. Novartis Business Overview Table 86. Novartis Product Table 87. Novartis Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 88. Novartis Recent Development Table 89. Boehringer Ingelheim Company Details Table 90. Boehringer Ingelheim Business Overview Table 91. Boehringer Ingelheim Product Table 92. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 93. Boehringer Ingelheim Recent Development Table 94. Teva Pharmaceutical Company Details Table 95. Teva Pharmaceutical Business Overview Table 96. Teva Pharmaceutical Product Table 97. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 98. Teva Pharmaceutical Recent Development Table 99. Abbvie Company Details Table 100. Abbvie Business Overview Table 101. Abbvie Product Table 102. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 103. Abbvie Recent Development Table 104. Merck Company Details Table 105. Merck Business Overview Table 106. Merck Product Table 107. Merck Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 108. Merck Recent Development Table 109. Akorn Company Details Table 110. Akorn Business Overview Table 111. Akorn Product Table 112. Akorn Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 113. Akorn Recent Development Table 114. Kyowa Hakko Kirin Pharma Business Overview Table 115. Kyowa Hakko Kirin Pharma Product Table 116. Kyowa Hakko Kirin Pharma Company Details Table 117. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 118. Kyowa Hakko Kirin Pharma Recent Development Table 119. Astellas Pharma Company Details Table 120. Astellas Pharma Business Overview Table 121. Astellas Pharma Product Table 122. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 123. Astellas Pharma Recent Development Table 124. Desitin Arzneimittel Company Details Table 125. Desitin Arzneimittel Business Overview Table 126. Desitin Arzneimittel Product Table 127. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 128. Desitin Arzneimittel Recent Development Table 129. Endo Pharmaceuticals Company Details Table 130. Endo Pharmaceuticals Business Overview Table 131. Endo Pharmaceuticals Product Table 132. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 133. Endo Pharmaceuticals Recent Development Table 134. F.Hoffmann-La Roche Company Details Table 135. F.Hoffmann-La Roche Business Overview Table 136. F.Hoffmann-La Roche Product Table 137. F.Hoffmann-La Roche Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 138. F.Hoffmann-La Roche Recent Development Table 139. H.Lundbeck Company Details Table 140. H.Lundbeck Business Overview Table 141. H.Lundbeck Product Table 142. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 143. H.Lundbeck Recent Development Table 144. Valeant Company Details Table 145. Valeant Business Overview Table 146. Valeant Product Table 147. Valeant Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 148. Valeant Recent Development Table 149. Apokyn Company Details Table 150. Apokyn Business Overview Table 151. Apokyn Product Table 152. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 153. Apokyn Recent Development Table 154. Orion Company Details Table 155. Orion Business Overview Table 156. Orion Product Table 157. Orion Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 158. Orion Recent Development Table 159. Stada Arzneimittel Company Details Table 160. Stada Arzneimittel Business Overview Table 161. Stada Arzneimittel Product Table 162. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 163. Stada Arzneimittel Recent Development Table 164. US WorldMeds Company Details Table 165. US WorldMeds Business Overview Table 166. US WorldMeds Product Table 167. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 168. US WorldMeds Recent Development Table 169. Bausch Health Company Details Table 170. Bausch Health Business Overview Table 171. Bausch Health Product Table 172. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$) Table 173. Bausch Health Recent Development Table 174. Research Programs/Design for This Report Table 175. Key Data Information from Secondary Sources Table 176. Key Data Information from Primary Sources List of Figures Figure 1. Global Parkinson's Disease Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Medications Therapeutics Features Figure 3. Medical Devices Therapeutics Features Figure 4. Global Parkinson's Disease Therapeutics Market Share by Application: 2020 VS 2026 Figure 5. Under 40 Years Old Case Studies Figure 6. 40-65 Years Old Case Studies Figure 7. Above 65 Years Old Case Studies Figure 8. Parkinson's Disease Therapeutics Report Years Considered Figure 9. Global Parkinson's Disease Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Parkinson's Disease Therapeutics Market Share by Regions: 2020 VS 2026 Figure 11. Global Parkinson's Disease Therapeutics Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Parkinson's Disease Therapeutics Market Share by Players in 2019 Figure 14. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2019 Figure 16. North America Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 25. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 27. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 29. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 31. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 33. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 35. Akorn Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 37. Kyowa Hakko Kirin Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 39. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 41. Desitin Arzneimittel Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 43. Endo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Endo Pharmaceuticals Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 45. F.Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 47. H.Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. H.Lundbeck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 49. Valeant Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Valeant Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 51. Apokyn Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Apokyn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 53. Orion Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Orion Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 55. Stada Arzneimittel Total Revenue (US$ Million): 2019 Compared with 2018 Figure 56. Stada Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 57. US WorldMeds Total Revenue (US$ Million): 2019 Compared with 2018 Figure 58. US WorldMeds Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 59. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018 Figure 60. Bausch Health Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Get Free Sample

Related Reports

COVID-19 Impact on Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

COVID-19 Impact on Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

COVID-19 Impact on Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

COVID-19 Impact on Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

COVID-19 Impact on Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)